Tavalisse Tablet
Product Images NDC 71332-001

3 FDA label images from Rigel Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tavalisse (NDC 71332-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rigel Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tavalisse 01)

Chemical Structure (Tavalisse 01)
Chemical structure of fostamatinib, the active ingredient in TAVALISSE tablets by Rigel Pharmaceuticals. The diagram shows the molecular arrangement including aromatic rings, phosphate groups, and various functional groups characteristic of the compound.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Label for Tavalisse (fostamatinib) tablets, 100 mg strength. The label indicates a package containing 60 oral tablets. It includes storage instructions to keep at 20°C to 25°C and advises keeping the tablet in the original container tightly closed. Manufactured by Rigel Pharmaceuticals, Inc., the label features a barcode and notes the product is for prescription use only.*
FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Principal Display Panel (150 mg Tablet Bottle Label)
Label for Tavalisse (fostamatinib) tablets, 150 mg oral dosage form. The package contains 60 tablets and is labeled as prescription only. Manufactured by Rigel Pharmaceuticals, Inc., the label includes storage instructions and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.